Bio Rad Labs Cl B (BIO.B) 140.58 $BIO.B Bio-Rad Unveils

New Post Public Reply Private Reply Replies (0) Message Board

Jun 26, 2016 at 4:20 AM

Bio Rad Labs Cl B (BIO. 140.58 $BIO.B

Bio-Rad Unveils Amplichek II Quality Control, the First in a Series of Controls for the Molecular Diagnostics Testing Market
Marketwired - Mon May 23, 7:30AM CDT
HERCULES, CA--(Marketwired - May 23, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced its entry into the rapidly growing molecular diagnostics testing market with the launch of Amplichek™ II quality control, which was recently issued a de novo clearance from the U.S. Food and Drug Administration (FDA).
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad posts 1Q profit
Automated Insights - Thu May 05, 4:12PM CDT
HERCULES, Calif. (AP) _ Bio-Rad Laboratories Inc. (BIO. on Thursday reported first-quarter profit of $12.3 million.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Reports First-Quarter 2016 Currency-Neutral Revenue Growth of Nearly 4 Percent
Marketwire Canada - Thu May 05, 3:16PM CDT
HERCULES, CA--(Marketwired - May 5, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, announced financial results today for the first quarter ended March 31, 2016.
BIO: 142.39 (+0.49), ILMN: 146.59 (+5.70), BIO.B: 140.58 (unch)

Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer
Marketwired - Mon Feb 08, 3:30PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO. and Propel Labs today announced that Bio-Rad has acquired a high performance analytical flow cytometer platform from Propel Labs that will enable advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries. Bio-Rad expects to launch the instrument later this year.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016
Marketwired - Tue Feb 02, 2:36PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO., a global provider of life science research and clinical diagnostic products, will report financial results fourth quarter and full year 2015 on Thursday, February 25, 2016, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Joins Food Safety Consortium With IBM and Mars, Incorporated
Marketwired - Tue Jan 12, 8:30AM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced that it has joined the Consortium for Sequencing the Food Supply Chain established in 2015 by scientists from IBM Research (NYSE: IBM) and Mars, Incorporated. The consortium is combining advanced genomics with new informatics tools to observe microbial communities in food and detect hazards in the food supply chain that can threaten safety.
IBM: 155.35 (+2.43), BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Named One of the 2015 Top 100 Bay Area Innovators by Thomson Reuters
Marketwired - Tue Jan 05, 3:15PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced that it was named one of the "Thomson Reuters 2015 Top 100 Bay Area Innovators."
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad's TANGO infinity Receives FDA 510(k) Clearance for U.S. Markets
Marketwired - Mon Dec 21, 3:21PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced that it has received U.S. Food and Drug Administration clearance to market its TANGO infinity(R) system in the U.S. The system automates routine blood typing and screening testing procedures for patients and donors.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Receives FDA Clearance for Its D-100 System for A1c Testing
Marketwired - Wed Dec 16, 5:19PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced that its D-100(TM) System for A1c testing has obtained clearance from the U.S. Food and Drug Administration to monitor the long-term blood glucose control of individuals with diabetes, as an aid in the diagnosis of diabetes, and to help identify those who may be at risk for developing the disease.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Reports Third-Quarter 2015 Financial Results
Marketwired - Tue Nov 03, 3:15PM CST
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO., a global provider of life science research and clinical diagnostic products, announced financial results today for the third quarter ended September 30, 2015.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad to Report Third-Quarter 2015 Financial Results Tuesday, November 3, 2015
Marketwired - Mon Oct 19, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, will report financial results for the third quarter 2015 on Tuesday, November 3, 2015, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Introduces the IH-500, a Fully Automated Random Access System for Blood Typing and Screening
Marketwired - Mon Aug 03, 7:30AM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO., today announced the launch of the IH-500, a fully automated random access system for blood typing and screening, providing small and medium-size transfusion medicine laboratories fast and reliable results in a 24/7 environment. The IH-500 system is available in Europe, Asia, Africa, Australia, and Latin America.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Announces U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab Assay, a Novel Next Generation HIV Diagnostic Test
Marketwired - Tue Jul 28, 3:15PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced that it has received U.S. Food and Drug Administration pre-market approval to offer its BioPlex(R) 2200 HIV Ag-Ab assay, the company's 5th generation HIV diagnostic test.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad to Report Second-Quarter 2015 Financial Results Thursday, August 6, 2015
Marketwired - Fri Jul 10, 3:29PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO., a global provider of life science research and clinical diagnostic products, will report financial results for the second quarter 2015 on Thursday, August 6, 2015, following the close of the market. The company will discuss these results in a conference call scheduled for 2 PM Pacific Daylight Time (5 PM Eastern Daylight Time) that day.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Bio-Rad Announces FDA Clearance for Diagnosing Diabetes With Its VARIANT II TURBO HbA1c Kit - 2.0
Marketwired - Tue Jun 09, 3:29PM CDT
Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO., a global provider of life science research and clinical diagnostic products, today announced that its VARIANT(TM) II TURBO HbA1c Kit - 2.0 has obtained clearance from the U.S. Food and Drug Administration for use as an aid in diagnosing diabetes and identifying people who may be at risk for developing the disease. This approval enhances the traditional use of the instrument by also providing the ability to screen and diagnose diabetes.
BIO: 142.39 (+0.49), BIO.B: 140.58 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VIZ Media Expands Reach with MangaPlaza Partnership

Manga Magic in the Digital Space Another day, another expansion, folks. VIZ Media's latest move to have its manga offerings available on MangaPlaza feels like a pretty shrewd play in the fierce arena of digital content. Who'd have thought decades ago that we'd be sitting here talking about digital comics like they’re the next Netflix? VIZ Media's expansion into...

BellRing Brands Lawsuit Hinges on Sales Misrepresentation

BellRing's Legal Tangle Deepens When it comes to drawing the line between having a good quarter and pulling the wool over investors' eyes, the latest lawsuit knotted up with BellRing Brands, Inc. (NYSE: BRBR) shows just how fine that line can be. This legal drama, filed on the not-so-distant date of January 22, 2026, isn't your garden-variety beef. We're talking...

Keith Strachan Elevates The Master Group's Strategy

Strachan Steps Up as Chief Commercial Officer Keith Strachan is stepping into the role of Chief Commercial Officer at The Master Group—big news up in St-Bruno-de-Montarville. Now, those not neck-deep in HVAC-R might shrug this one off, but for those eyeing the industry, this is where the cards start to shuffle in North America. Master’s shift isn't just paper-pushing;...

MPLX Adds Industry Veterans to Board Leadership

A New Era for MPLX's Board Nothing shakes up the scene like announcing two heavyweights joining the board, and that's exactly what MPLX LP (NYSE: MPLX) just pulled off. Micheal G. Dunn and Bruce L. Niemeyer are coming onboard, effective November 1, 2026. With pedigrees that could make any industry insider nod in approval, these guys bring decades of experience to the...

Webull Faces Class Action: Investor Impact Deep Dive

What's Going On with Webull? Ah, Webull Corporation, you're in the hot seat now. If you blinked on October 7th, you might have missed a monumental 19.09% cliff dive in Webull's stock, tumbling down to a humble $5.89. The roar wasn't just the market reacting; it was the sonic boom of a class action lawsuit on their heels, alleging some slick legal sledding with misleading...

Wood Partners Expands Charlotte Footprint with New Project

Charlotte's Expansion Beckons New Development at Village Park Charlotte's skyline is about to get a new neighbor in a growing district, as Wood Partners is set to break ground yet again, unveiling its ambitious plans for Village Park. This is not just a hodgepodge construction talk—it’s the company’s latest effort to plant its flag deep in the heart of the Queen...

Duolingo Lawsuit Looms Over Securities Allegations

Duolingo Lawsuit: A New Headache for Investors Seems like every time you blink, another tech darling is getting dragged to court, and now it's Duolingo's turn to face the music. They're locked in a class action lawsuit food-fight over violations of the Securities Exchange Act of 1934, specifically, §§10(b) and 20(a), and Rule 10b-5. The Core of Allegations Against...

Young Leaders Drive Be Strong’s Mental Health Movement

New Voices at the Helm Today’s youth aren’t just tomorrow's leaders; they’re stepping up now. Groups like Be Strong’s newly minted National Student Advisory Board are proving that. Sixteen kids across eleven states are diving headfirst into transforming mental health narratives. This ain't just some school club. These young guns are gearing up to reshape how we...

Historic Williamsburg Loft Gets a Modern Makeover

Breathing New Life into a Brooklyn Classic Alright, picture this: You're stepping into a century-old Brooklyn loft, expecting dust, aged wood, maybe a ghost or two. What you actually find is art wrapped in brass with a splash of modern flair. This ain't just any loft, folks—it's the latest trophy on the mantle for Gallery KBNY, a design-build firm known for its...

Cat Financial Shows Solid Q3 Growth Amid Challenges

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...